Pre-Clinical Investigation of Keratose as an Excipient of Drug Coated Balloons

Pre-Clinical Investigation of Keratose as an Excipient of Drug Coated Balloons

Background: Drug-coated balloons (DCBs), which deliver anti-proliferative drugs with the aid of excipients, have emerged as a new endovascular therapy for the treatment of peripheral arterial disease. In this study, we evaluated the use of keratose (KOS) as a novel DCB-coating excipient to deliver a...

Full description

Bibliographic Details
Main Authors: Emily Goel, Megan Erwin, Claire V. Cawthon, Carson Schaff, Nathaniel Fedor, Trevor Rayl, Onree Wilson, Uwe Christians, Thomas C. Register, Randolph L. Geary, Justin Saul, Saami K. Yazdani
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Molecules
Subjects:
Keratose
drug-coated balloon
paclitaxel
drug delivery
pre-clinical
peripheral arterial disease
Online Access:https://www.mdpi.com/1420-3049/25/7/1596

Internet

https://www.mdpi.com/1420-3049/25/7/1596

Similar Items